FMB you always amaze me. The key here, to my eye, is the partner in the trial is 'a large pharmaceutical company'; that is ok by me, I dont trust big pharma, but large pharma is good. So AT1 provide the kit, and Lumos does 'something'. What are manufacturing services? Is your 'value of the test' and 'how many readers' and 'plopping the test strip in the reader' included in the 700k to $1 mill of fees?
If we assume the trial goes 9 months that can be a 'new' $250k a quarter on services. Man, it would be great for Lumos to actually spell out what services generated what revenue in the blanket 'service $ they report'. And it would be great for Lumos to spell out what products generated what revenue in the 'product $ they report'. For all we know they are running a brothel in Vegas as part of their services and selling used office furniture on eBay as part of their product. We will never know. We only get two numbers.... services $ and product $ and maybe cash flow.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)